Olav Engebråten

1.6k total citations
18 papers, 417 citations indexed

About

Olav Engebråten is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Olav Engebråten has authored 18 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in Olav Engebråten's work include MRI in cancer diagnosis (4 papers), Medical Imaging Techniques and Applications (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Olav Engebråten is often cited by papers focused on MRI in cancer diagnosis (4 papers), Medical Imaging Techniques and Applications (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Olav Engebråten collaborates with scholars based in Norway, United States and Sweden. Olav Engebråten's co-authors include Gunhild M. Mælandsmo, Geir Olav Hjortland, Henry Hirschberg, Jahn M. Nesland, Steen J. Madsen, Qian Peng, Scott Friesen, Siver Andreas Moestue, Ingrid S. Gribbestad and Lina Prasmickaite and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Annals of Oncology.

In The Last Decade

Olav Engebråten

17 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olav Engebråten Norway 11 186 109 100 87 83 18 417
Sarwat Naz United States 11 233 1.3× 50 0.5× 93 0.9× 83 1.0× 117 1.4× 14 394
Sarah Tucker Marrison United States 6 276 1.5× 145 1.3× 106 1.1× 172 2.0× 123 1.5× 10 603
Elodie A. Pérès France 14 128 0.7× 54 0.5× 102 1.0× 95 1.1× 93 1.1× 27 462
Nianhua Ding China 11 202 1.1× 105 1.0× 74 0.7× 100 1.1× 223 2.7× 17 565
Kathryn E. Aziz United States 10 477 2.6× 92 0.8× 111 1.1× 173 2.0× 123 1.5× 17 895
Gianfranco Baronzio Italy 10 112 0.6× 149 1.4× 50 0.5× 66 0.8× 62 0.7× 23 354
Jindian Li China 14 136 0.7× 134 1.2× 54 0.5× 31 0.4× 96 1.2× 33 487
Bastien Doix Belgium 9 289 1.6× 193 1.8× 162 1.6× 249 2.9× 134 1.6× 10 666
Martin Proescholdt Germany 12 288 1.5× 87 0.8× 46 0.5× 168 1.9× 90 1.1× 28 574
Jiangtao Sun China 12 227 1.2× 113 1.0× 72 0.7× 115 1.3× 81 1.0× 21 547

Countries citing papers authored by Olav Engebråten

Since Specialization
Citations

This map shows the geographic impact of Olav Engebråten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olav Engebråten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olav Engebråten more than expected).

Fields of papers citing papers by Olav Engebråten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olav Engebråten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olav Engebråten. The network helps show where Olav Engebråten may publish in the future.

Co-authorship network of co-authors of Olav Engebråten

This figure shows the co-authorship network connecting the top 25 collaborators of Olav Engebråten. A scholar is included among the top collaborators of Olav Engebråten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olav Engebråten. Olav Engebråten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Geier, Oliver, Olav Engebråten, Line Brennhaug Nilsen, et al.. (2023). MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients. Cancers. 15(18). 4662–4662. 2 indexed citations
2.
Pettersen, Solveig, et al.. (2023). Breast cancer patient-derived explant cultures recapitulate in vivo drug responses. Frontiers in Oncology. 13. 1040665–1040665. 10 indexed citations
3.
Pandya, Abhilash, Tore‐Geir Iversen, Siver Andreas Moestue, et al.. (2021). Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft. Nanomaterials. 11(5). 1140–1140. 10 indexed citations
4.
Erdélyi, Katalin, Tamás Ditrói, Henrik J. Johansson, et al.. (2021). Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation. Proceedings of the National Academy of Sciences. 118(45). 60 indexed citations
5.
Haugen, Mads H., Ole Christian Lingjærde, Oslo Garred, et al.. (2019). Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients. Annals of Oncology. 30. iii8–iii8.
6.
Prasmickaite, Lina, Solveig Pettersen, Silje Nord, et al.. (2018). Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4. Molecular Oncology. 12(9). 1540–1558. 36 indexed citations
7.
Kim, Eugene, Riyas Vettukattil, Astrid Jullumstrø Feuerherm, et al.. (2016). Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. BMC Cancer. 16(1). 191–191. 25 indexed citations
8.
Esmaeili, Morteza, Siver Andreas Moestue, Bob C. Hamans, et al.. (2014). In Vivo 31P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts. Journal of Magnetic Resonance Imaging. 41(3). 601–609. 10 indexed citations
9.
Bagherifam, Shahla, Frode Miltzow Skjeldal, Gareth Griffiths, et al.. (2014). pH-Responsive Nano Carriers for Doxorubicin Delivery. Pharmaceutical Research. 32(4). 1249–1263. 21 indexed citations
10.
Kristian, Alexandr, Line Brennhaug Nilsen, Kathrine Røe, et al.. (2013). Dynamic 18 F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts. Nuclear Medicine and Molecular Imaging. 47(3). 173–180. 7 indexed citations
11.
Qu, Hong, et al.. (2013). Dynamic18F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts. Acta Oncologica. 52(7). 1566–1572. 25 indexed citations
12.
Moestue, Siver Andreas, Alexandr Kristian, Anna M. Bofin, et al.. (2013). Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Research. 15(1). R16–R16. 40 indexed citations
13.
Esmaeili, Morteza, Tone F. Bathen, Olav Engebråten, et al.. (2013). Quantitative 31P HR‐MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts. Magnetic Resonance in Medicine. 71(6). 1973–1981. 15 indexed citations
14.
Borgen, Elin, Anne Fangberget, Cecilie Bendigtsen Schirmer, et al.. (2013). Abstract P1-08-21: Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant breast cancer treatment including bevacizumab. Cancer Research. 73(24_Supplement). P1–8. 2 indexed citations
15.
Engesæter, Birgit, et al.. (2011). Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells. Cancer Biology & Therapy. 12(1). 47–58. 19 indexed citations
16.
Prasmickaite, Lina, Hanne K. Høifødt, Zhenhe Suo, et al.. (2010). Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells. Pigment Cell & Melanoma Research. 23(3). 449–451. 21 indexed citations
17.
Engesæter, Birgit, Anette Bonsted, Kristian Berg, et al.. (2005). PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particles. Cancer Gene Therapy. 12(5). 439–448. 21 indexed citations
18.
Friesen, Scott, Geir Olav Hjortland, Steen J. Madsen, et al.. (2002). 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (Review). International Journal of Oncology. 21(3). 577–82. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarwat Naz Breakdown of academic impact, for papers by Sarah Tucker Marrison Breakdown of academic impact, for papers by Elodie A. Pérès Breakdown of academic impact, for papers by Nianhua Ding Breakdown of academic impact, for papers by Kathryn E. Aziz Breakdown of academic impact, for papers by Gianfranco Baronzio Breakdown of academic impact, for papers by Jindian Li Breakdown of academic impact, for papers by Bastien Doix Breakdown of academic impact, for papers by Martin Proescholdt Breakdown of academic impact, for papers by Jiangtao Sun
Rankless by CCL
2026